Protective role of berberine on ulcerative colitis through modulating enteric glial cells–intestinal epithelial cells–immune cells interactions
Open Access
- 5 September 2019
- journal article
- research article
- Published by Elsevier BV in Acta Pharmaceutica Sinica. B
- Vol. 10 (3), 447-461
- https://doi.org/10.1016/j.apsb.2019.08.006
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Commission of Shanghai Municipality, China (18431907100)
This publication has 53 references indexed in Scilit:
- New Perspective on Dextran Sodium Sulfate Colitis: Antigen-Specific T Cell Development during Intestinal InflammationPLOS ONE, 2013
- Enteric Glia Cells Attenuate Cytomix-Induced Intestinal Epithelial Barrier BreakdownPLOS ONE, 2013
- Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Oxidative stressBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activationEuropean Journal of Pharmacology, 2010
- The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy SubjectsThe Open Biochemistry Journal, 2010
- In vivo imaging of reactive oxygen and nitrogen species in inflammation using the luminescent probe L-012Free Radical Biology & Medicine, 2009
- The role of substance P in inflammatory diseaseJournal of Cellular Physiology, 2004
- Substance P increases neutrophil adhesion to human umbilical vein endothelial cellsBritish Journal of Pharmacology, 2003
- Role of enteric glial cells in inflammatory bowel diseaseGlia, 2002